Read by QxMD icon Read

Vascular Medicine

Edoardo Virgilio, Luciano Novi, Paolo Triveri, Genoveffa Balducci
No abstract text is available yet for this article.
December 8, 2016: Vascular Medicine
Caitlin W Hicks, Alireza Najafian, Alik Farber, Matthew T Menard, Mahmoud B Malas, James H Black, Christopher J Abularrage
Both open surgery and endovascular peripheral interventions have been shown to effectively improve outcomes in patients with peripheral arterial disease, but minimal data exist comparing outcomes performed at and below the knee. The purpose of this study was to compare outcomes following infrageniculate lower extremity open bypass (LEB) versus peripheral vascular intervention (PVI) in patients with critical limb ischemia. Using data from the 2008-2014 Vascular Quality Initiative, 1-year primary patency, major amputation, and mortality were compared among all patients undergoing LEB versus PVI at or below the knee for rest pain or tissue loss...
December 6, 2016: Vascular Medicine
Immad Sadiq, Samuel Z Goldhaber, Ping-Yu Liu, Gregory Piazza
Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis minimizes the risk of intracranial bleeding compared with systemic full-dose fibrinolytic therapy for pulmonary embolism (PE). However, major bleeding is nevertheless a potential complication. We analyzed the 150-patient SEATTLE II trial of submassive and massive PE patients to describe those who suffered major bleeding events following ultrasound-facilitated, catheter-directed, low-dose fibrinolysis and to identify risk factors for bleeding. Major bleeding was defined as GUSTO severe/life-threatening or moderate bleeds within 72 hours of initiation of the procedure...
December 1, 2016: Vascular Medicine
David Hageman, Lindy Nm Gommans, Marc Rm Scheltinga, Joep Aw Teijink
Some believe that certain patients with intermittent claudication (IC) may be unsuitable for supervised exercise therapy (SET), based on the presence of comorbidities and the possibly increased risks. We conducted a systematic review (MEDLINE, EMBASE and CENTRAL) to summarize evidence on the potential influence of diabetes mellitus (DM) on the response to SET. Randomized and nonrandomized studies that investigated the effect of DM on walking distance after SET in patients with IC were included. Considered outcome measures were maximal, pain-free and functional walking distance (MWD, PFWD and FWD)...
November 30, 2016: Vascular Medicine
Umberto G Rossi, Pierluca Torcia, Maurizio Cariati
No abstract text is available yet for this article.
November 7, 2016: Vascular Medicine
Raghavendra L Girijala, Farida Sohrabji, Ruth L Bush
Stroke is a leading cause of death among women in the United States, and women are more affected by stroke than men. With women living longer than men, women experience not only a higher incidence of stroke but also more negative outcomes. Despite its lethal impact and high morbidity rate, the road from innovative bench research to improved clinical outcomes has been slow. This review explores the differential physiology, epidemiology, and clinical presentation of stroke between men and women, as well as the current status of laboratory and clinical data...
November 3, 2016: Vascular Medicine
Eliane Younes, Fady Haddad, Hani Tamim, Ali Taher, Imad BouAkl, Hassan A Chami
At some institutions, lower extremity ultrasound (LEUS) is performed routinely to screen for deep venous thrombosis (DVT) prior to sequential compression device (SCD) application. We set out to evaluate whether screening for DVT with LEUS is warranted prior to SCD application in critically ill adults with contraindications to anticoagulation. A total of 257 critically ill adults, who underwent LEUS screening prior to SCD application, were identified retrospectively using vascular laboratory records. Outcomes and delay in SCD application associated with screening for DVT were determined...
November 2, 2016: Vascular Medicine
John P Winters, Christopher S Morris, Chris E Holmes, Patricia Lewis, Anant D Bhave, Kenneth E Najarian, Joseph T Shields, William Charash, Mary Cushman
Published reports indicate low retrieval rates for retrievable inferior vena cava (IVC) filters. We performed a historic-controlled study of a 5-year intervention (March 2007 to February 2012) to improve IVC filter retrieval at a university medical center serving a rural area. All adults with a retrievable filter placed were included, except those with a life expectancy <6 months. The intervention included initial verbal counseling and printed educational materials, correspondence after discharge, and a hematology consultation...
November 2, 2016: Vascular Medicine
Melissa J Baldwin, Aleksandra Policha, Thomas Maldonado, Jade S Hiramoto, Stephen Honig, Michael S Conte, Jeffrey Berger, Caron B Rockman
The purpose of the current study was to investigate the association between bone mineral density (BMD) scores and the prevalence of peripheral artery disease (PAD) in a large cohort of subjects who underwent arterial Doppler assessments and calcaneal bone densitometry. The study was performed using data obtained from Life Line Screening Inc. Subjects were self-selected and paid for screening tests. The prevalence of PAD was significantly higher in men with osteopenia (4.5%) and osteoporosis (10.9%) compared to men with normal BMD (3...
October 30, 2016: Vascular Medicine
Héctor A Carmona-Ruiz, Juan Carlos Heredia-Gutiérrez, Oscar Orihuela-Rodríguez
No abstract text is available yet for this article.
October 5, 2016: Vascular Medicine
Akhilesh K Sista, Larry E Miller, Susan R Kahn, Jeffrey A Kline
Long-term right ventricular (RV) function, functional capacity, exercise capacity, and quality of life following pulmonary embolism (PE), and the impact of thrombolysis, are unclear. A systematic review of studies that evaluated these outcomes with ⩾ 3-month mean follow-up after PE diagnosis was performed. For each outcome, random effects meta-analyses were performed. Twenty-six studies (3671 patients) with 18-month median follow-up were included. The pooled prevalence of RV dysfunction was 18.1%. Patients treated with thrombolysis had a lower, but not statistically significant, risk of RV dysfunction versus those treated with anticoagulation (odds ratio: 0...
October 5, 2016: Vascular Medicine
Yasuhiro Suyama, Mitsumasa Kishimoto, Shinji Togashi, Yasushi Terada, Masato Okada
No abstract text is available yet for this article.
September 28, 2016: Vascular Medicine
John D Kakisis, Konstantinos G Moulakakis, George S Sfyroeras, George Geroulakos
No abstract text is available yet for this article.
September 15, 2016: Vascular Medicine
Robert T Eberhardt
No abstract text is available yet for this article.
December 2016: Vascular Medicine
(no author information available yet)
No abstract text is available yet for this article.
December 2016: Vascular Medicine
Rafael Noronha Cavalcante, Joaquim Mauricio Motta-Leal-Filho, Francisco Leonardo Galastri, Bruna De Fina, Breno Boueri Affonso, Jorge Eduardo de Amorim, Nelson Wolosker, Felipe Nasser
No abstract text is available yet for this article.
December 2016: Vascular Medicine
Zhongzhi Jia, Kai Wang, Guomin Jiang
No abstract text is available yet for this article.
December 2016: Vascular Medicine
Gregory J Landry, Rakendu Shukla, Auddri Rahman, Amir F Azarbal, Erica L Mitchell, Timothy K Liem, Gregory L Moneta
We sought to determine if symptomatic cardiogenic limb emboli have a random distribution or if there are demographic or echocardiographic factors that predict site of embolization, limb salvage and mortality. Upper (UE) and lower extremity (LE) emboli were evaluated over a 16-year period (1996-2012). Demographic (age, gender, smoking, medical comorbidities) and echocardiographic data were analyzed to determine predictors of embolic site. All symptomatic patients underwent surgical revascularization. Limb salvage and mortality were compared with Kaplan-Meier analysis...
December 2016: Vascular Medicine
Samuel Z Goldhaber, Henry Eriksson, Ajay Kakkar, Sebastian Schellong, Martin Feuring, Mandy Fraessdorf, Joerg Kreuzer, Elke Schueler, Sam Schulman
It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc analyses of data from RE-COVER(®), RE-COVER(™) II, and RE-MEDY(™) were performed to compare dabigatran etexilate with warfarin for the treatment and prevention of venous thromboembolism (VTE) in patients with thrombophilia or antiphospholipid antibody syndrome (APS). There were no significant differences in symptomatic VTE/VTE-related deaths between dabigatran etexilate and warfarin in patients with or without thrombophilia...
December 2016: Vascular Medicine
Alan T Hirsch, Jeremy R Van't Hof, Marc Bonaca
No abstract text is available yet for this article.
December 2016: Vascular Medicine
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"